Keywords: European Union, CHMP, Besilesomab, amifampridine, sildenafil, lefluonomide, tadalafil, bivalirudin, duloxetine, telmisartan

Batch of approvals and positive opinions from EU’s CHMP

Article | 26 October 2009

Print This

The European medicines Agency’s (EMEA) Committee for Medicinal Products for Human Use, (CHMP) adopted positive opinions at its October 19 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in